Roche has nearly 200 potential drugs in development, a third of them based on new chemical compounds, said George Abercrombie, chief executive at Hoffmann-La Roche, the company’s U.S ...

NUTLEY — The 116-acre campus that was once home to pharmaceutical giant Hoffmann-La Roche did not sit empty for long. The turnaround was so fast that development exceeded expectations, and it ...

Delhi High Court refuses to direct Zydus to disclose manufacturing process of Sigrima: Gireesh Babu, New Delhi Saturday, July 26, 2025, 08:00 Hrs [IST] The Delhi High Court has sa ...

Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...

NUTLEY — The New Jersey Economic Development Authority (EDA) has offered two big carrots to Ralph Lauren Corp. and Quest Diagnostics Inc. to move their operations to the former Hoffmann-La Roche ...

Researchers at F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have synthesized benzimidazole derivatives acting as serine/threonine-protein kinase SIK2 (QIK) and/or SIK1 (SNF1LK) and/or SIK3 ...

F. Hoffmann-La Roche Ltd: Early data suggest Roche's NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A: ...

PITTSBURGH — Generic drug maker Mylan has entered an agreement with Hoffmann La Roche concerning its version of an oral chemotherapy drug. Mylan announced Wednesday that it had entered a ...